2009
DOI: 10.1039/b806468g
|View full text |Cite
|
Sign up to set email alerts
|

Molecular recognition of pertechnetate and perrhenate

Abstract: This tutorial review covers the chemistry of artificial receptors designed to recognize the pertechnetate and perrhenate anions. It focuses on the molecular features that give rise to effective and selective complexation. Specific receptor classes are discussed in the context of available solution-phase and solid-state data with differences between pertechnetate and perrhenate binding behavior being highlighted where appropriate.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
147
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 174 publications
(148 citation statements)
references
References 58 publications
1
147
0
Order By: Relevance
“…Synthesis In the crystal lattice of 1, two arms of two tricopper ions are connected to one another through a Cu(µ-Cl) 2 Cu quadrilateral, at a Cu···Cu separation of 3.432 Å ( Figure 2B). The bridging of the two Cl -ions is unsymmetrical.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Synthesis In the crystal lattice of 1, two arms of two tricopper ions are connected to one another through a Cu(µ-Cl) 2 Cu quadrilateral, at a Cu···Cu separation of 3.432 Å ( Figure 2B). The bridging of the two Cl -ions is unsymmetrical.…”
Section: Resultsmentioning
confidence: 99%
“…Crystallographic studies of 1 revealed that the three symmetry-related arms each coordinate a {Cu II Cl} unit, and two molecules of 1 are connected to one another through a Cu(µ-Cl) 2 Cu bridge, extending the molecular structure to form a two-dimensional layer.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Email: yikeda@nr.titech. ac.jp extractants have been reported to act as a poor ligand for ReO 4[23][24][25]. Recently, the novel extractants, 2,2 -(methylimino)bis(N,N -dialkylacetamide) (MIDRA) and 2,2 -(iminium)bis(N,N -dialkylacetamide) (IDRA), have been developed [26].…”
Section: Introductionmentioning
confidence: 99%